1Genazzani AR, Gadducci A, Gambaccicni M. Hormone replacement therapy and cancer. Climacteric, 2001,4(3) : 191.
2Hartge P, Hoover R, McGowan L, et al. Menopause and ovarian cancer. Am J Epidemiol, 1988,127(5) :990.
3Hempling RE, Wong C, Piver MS, et al. Hormone replacement therapy as a risk factor for epithelial ovarian caner: results of a case control study. Obstet Gynecol, 1997,89(6): 1012.
4Coughlin SS, Giustozzi A, Smith SJ, et al. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol,2000,53(4 ) : 367.
5Sittisomwong T, Suneja A, Kudelka AP, et al. Estrogen replacement therapy and ovarian cancer. Eur J Gynecol, 2000,21 (4) : 348.
6Rodriguez C, Patel AV, Calle EE, et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA, 2001,285 ( 11 ) : 1460.
7Negri E,Tionon A, Beral V, et al. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies. Int J Cancer, 1999,80(6) :848.
8Garg PP, Kerlikowske K, Subak L, et al. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gyneeol, 1998,92 (3) : 472.
9Purdie DM, Bain CJ, Siskind V, et al. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer, 1999,81 (3) :559.
10Risch HA. Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol, 1996,63(2) :254.
6Forabosco A, Criscuol M, Coukos G, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol, 1992,73 ( 5 ): 570 ～574.
7Heimer Gm. Estriol in the postmenopause. Acta Obstet Gyneocol Sc and Suppl, 1987,139:1 - 23.
8Lobo RA. Benefit and risk of estrogen replacement therapy. Am J Obstet Gynecol, 1995,173 (3): 982 - 9.
